Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Reexamination Certificate
2005-03-29
2010-12-14
Steadman, David J (Department: 1656)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
Reexamination Certificate
active
07851589
ABSTRACT:
A polypeptide exhibiting the effect of inhibiting Ca2+leakage in a target cell, the polypeptide having the amino acid sequence of any of SEQ ID NOs: 3 to 9 or an amino acid sequence obtained through deletion, insertion, substitution, or addition of one or more amino acids in the aforementioned amino acid sequence; a polynucleotide encoding the polypeptide; and a pharmaceutical composition containing, as an active ingredient, the polypeptide or an expression product of the polynucleotide.
REFERENCES:
patent: 2001/57188 (2001-08-01), None
“Introduction to Protein Structure,” Branden and Tooze, Garland Publishing, Inc., New York, 1991, at p. 247.
Lam et al., J. Biol. Chem. 270:26511-26522, 1995.
Abaza et al., J. Prot. Chem. 11:433-444, 1992.
Gausterer et al., Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chem. 6:29-45, 2007.
Dang et al., Clin Cancer Res 5:471-474, 1999.
Fox, Nat Biotechnol 21:217, 2003.
Juengst, BMJ 326:1410-1411, 2003.
Yamamoto et al., Circulation 117:762-772, 2008.
Takeshi Yamamoto, et al. “Postulated Role of Interdomain Interaction Within the Ryanodine Receptor in Ca2+ Channel Regulation”, Journal of Biological Chemistry, XP 002427006, vol. 275, No. 16, Apr. 21, 2000, pp. 11618-11625.
Masafumi Yano, et al. “FKBP12.6-Mediated Stabilization of Calcium-Release Channel(Ryanodine Receptor) as a Novel Therapeutic Strategy Against Heart Failure”, Circulation, American Heart Association, XP002990501, vol. 107, No. 3. Jan. 2003, pp. 477-484.
Takeshi Yamamoto, et al. “Interruption of Specific Domain-Domain Interaction Within Ryanodine Receptor Mediates Stabilization of Ryanodine Receptor in Failing Hearts”, Circulation, XP 009081455, vol. 114, No. 18, Oct. 31, 2006, 2 Pages.
Tunwell, Richard E. A. et al.,“The Human Cardiac Muscle Ryanodine Receptor-calcium Release Channel: Identification, Primary Structure and Topological Analysis” Biochem J., vol. 318, pp. 477-487, 1996.
Lui, Zheng et al.,“Three-dimensional Reconstruction of the Recombinant Type 2 Ryanodine Receptor and Localization of Its Divergent Region 1”, The Jumal of Biological Chemistry, vol. 277, No. 48, pp. 46712-46719,2002.
D.J. Beuckelmann, et al., “Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure”, Circulation Journal of the American Heart Association, 85, 1046-1055 (1992).
J.K. Gwathmey, et al., “Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure”, Circular Research Journal of the American Heart Association, 61, 70-76 (1987).
Debra L. Baker, et al., “Targeted Overexpression of the Sarcoplasmic Reticulum Ca2+-ATPase Increases Cardiac Contractility in Transgenic Mouse Hearts”, Circulation Research Journal of the American Heart Association, 83, 1205-1214 (1998).
Götz Münch, et al., “Unchanged protein expression of sarcoplasmic reticulum Ca2+-ATPase, phospholamban, and calsequestrin in terminally failing human myocardium”, J Mol Med, 76, 434-441 (1998).
Steven O. Marx, et al., “PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor): Defective Regulation in Failing Hearts”, Cell, 101, 365-376 (2000).
Andrew R. Marks, “Clinical Implications of Cardiac Ryanodine Receptor/Calcium Release Channel Mutations Linked to Sudden Cardiac Death”, Circulation Journal of the American Heart Association, 106, 8-10 (2002).
Xander H.T. Wehrens, et al., “FKBP12.6 Deficiency and Defective Calcium Release Channel (Ryanodine Receptor) Function Linked to Exercise-Induced Sudden Cardiac Death”, Cell, 113, 829-840 (2003).
Masafumi Yano, et al., “Altered Stoichiometry of FKBP12.6 Versus Ryanodine Receptor as a Cause of Abnormal Ca2+Leak Through Ryanodine Receptor in Heart Failure”, Circulation Journal of the American Heart Association, 102, 2131-2136 (2000).
Matsuzaki Masunori
Yamamoto Takeshi
Yano Masafumi
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Otsuka Pharmaceutical Co. Ltd.
Steadman David J
LandOfFree
Polypeptide derived from the ryanodine receptor that... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptide derived from the ryanodine receptor that..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide derived from the ryanodine receptor that... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4200987